$INDV news
The latest INDV stock news: headlines, filings, AI summaries and sentiment for $INDV, updated around the clock.
- Piper Sandler Resumes Coverage of Supernus Pharmaceuticals with Overweight Rating
- Supernus, Inc. - 8-K Filing
- Indivior Pharmaceuticals Completes Merger with Supernus Pharmaceuticals
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Indivior Pharmaceuticals, Inc. - 10-Q Filing
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Huron Consulting Group to Join S&P SmallCap 600 on November 3
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Indivior Announces Merger with Supernus in $2.2 Billion All-Stock Deal
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Supernus and Indivior Announce All-Stock Merger to Form Diversified CNS Biopharmaceutical Company
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Indivior Reports Strong Second-Quarter Results with Beat on Earnings and Revenue
- Indivior Pharmaceuticals, Inc. - 8-K Filing
- Divisadero Street Capital Management Sells $74.8 Million in Indivior Shares
- Divisadero Street Capital Management Sells $74.8 Million Worth of Indivior Shares
- Madison Avenue Partners Invests $143 Million in Indivior as Shares Rise Over 200%
- Madison Avenue Partners Invests $143 Million in Indivior as Shares Rise Over 200%
- Claret Asset Management Invests $21.5 Million in Indivior Amid Significant Stock Rally
- Indivior Reports Strong Q1 2026 Earnings with Revenue Growth and Operational Improvements
- Indivior Reports Strong Q1 2026 Results with Revenue and Profit Growth